Terms: = Lung cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
1005 results:
1. Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score.
Zhang C; Li S; Shen L; Teng X; Xiao Y; Yang W; Lu Z
Cancer Immunol Immunother; 2024 May; 73(7):123. PubMed ID: 38727812
[TBL] [Abstract] [Full Text] [Related]
2. PGE
Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
[TBL] [Abstract] [Full Text] [Related]
3. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
Ma C; Gu Z; Yang Y
J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237
[TBL] [Abstract] [Full Text] [Related]
4. Deep phenotyping of dementia in a multi-ethnic cardiovascular cohort: The Multi-Ethnic Study of Atherosclerosis (MESA).
Ostovaneh MR; Hughes TM; Wu CO; McClelland RL; Casanova R; Bluemke DA; Tracy RP; Shea S; Heckbert SR; Lima JAC; Ambale-Venkatesh B
PLoS One; 2024; 19(4):e0298952. PubMed ID: 38635767
[TBL] [Abstract] [Full Text] [Related]
5. T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC.
Yi L; Xu Z; Ma T; Wang C; Wei P; Xiao B; Zhang H; Che N; Liu Z; Han Y
Cancer Immunol Immunother; 2024 Apr; 73(6):99. PubMed ID: 38619623
[TBL] [Abstract] [Full Text] [Related]
6. Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition.
Baker FL; Smith KA; Mylabathula PL; Zúñiga TM; Diak DM; Batatinha H; Niemiro GM; Seckeler MD; Pedlar CR; O'Connor DP; Colombo J; Katsanis E; Simpson RJ
Cancer Res Commun; 2024 May; 4(5):1253-1267. PubMed ID: 38592213
[TBL] [Abstract] [Full Text] [Related]
7. il-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.
Roser LA; Sakellariou C; Lindstedt M; Neuhaus V; Dehmel S; Sommer C; Raasch M; Flandre T; Roesener S; Hewitt P; Parnham MJ; Sewald K; Schiffmann S
J Immunotoxicol; 2024 Dec; 21(1):2332177. PubMed ID: 38578203
[TBL] [Abstract] [Full Text] [Related]
8. CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production.
Na K; Lee S; Kim DK; Kim YS; Hwang JY; Kang SS; Baek S; Lee CY; Yang SM; Han YJ; Kim MH; Han H; Kim Y; Kim JH; Jeon S; Byeon Y; Lee JB; Lim SM; Hong MH; Pyo KH; Cho BC
Front Immunol; 2024; 15():1336246. PubMed ID: 38515751
[TBL] [Abstract] [Full Text] [Related]
9. Antiproliferative and immunomodulative potential of Citrullus colocynthis and its bioactive compounds in human lymphocytes and lung cells.
Stein C; Voigts J; Niederreiter L; Kowarschik S; Huber R; Lüth VM
J Ethnopharmacol; 2024 Jun; 328():118053. PubMed ID: 38499257
[TBL] [Abstract] [Full Text] [Related]
10. Mathematical modeling and control of lung cancer with il2 cytokine and anti-PD-L1 inhibitor effects for low immune individuals.
Ahmad A; Kulachi MO; Farman M; Junjua MU; Bilal Riaz M; Riaz S
PLoS One; 2024; 19(3):e0299560. PubMed ID: 38483931
[TBL] [Abstract] [Full Text] [Related]
11. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin-2-induced skin inflammation.
Sommer C; Cohen JN; Dehmel S; Neuhaus V; Schaudien D; Braun A; Sewald K; Rosenblum MD
Eur J Immunol; 2024 Apr; 54(4):e2350580. PubMed ID: 38430129
[TBL] [Abstract] [Full Text] [Related]
13. Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations.
Cappelletto E; Fasiolo LT; Salizzato V; Piccin L; Fabozzi A; Contato A; Bianco PD; Pasello G; Chiarion-Sileni V; Gion M; Fabricio ASC
Int J Biol Markers; 2024 Mar; 39(1):9-22. PubMed ID: 38407953
[TBL] [Abstract] [Full Text] [Related]
14. Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients.
Ma C; Zhao H; Sun Y; Ding W; Wang H; Li Y; Gu Z
Cell Signal; 2024 May; 117():111105. PubMed ID: 38369264
[TBL] [Abstract] [Full Text] [Related]
15. Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned.
Borgers JSW; van Schijndel AW; van Thienen JV; Klobuch S; Seijkens TTP; Tobin RP; van Heerebeek L; Driessen-Waaijer A; Rohaan MW; Haanen JBAG
ESMO Open; 2024 Feb; 9(2):102383. PubMed ID: 38364453
[TBL] [Abstract] [Full Text] [Related]
16. Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos.
Jones DM; Tuazon JA; Read KA; Leonard MR; Pokhrel S; Sreekumar BK; Warren RT; Yount JS; Collins PL; Oestreich KJ
J Immunol; 2024 Apr; 212(7):1129-1141. PubMed ID: 38363226
[TBL] [Abstract] [Full Text] [Related]
17. Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.
Sundström P; Dutta N; Rodin W; Hallqvist A; Raghavan S; Quiding Järbrink M
Oncoimmunology; 2024; 13(1):2312631. PubMed ID: 38343750
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
Amaria R; Knisely A; Vining D; Kopetz S; Overman MJ; Javle M; Antonoff MB; Tzeng CD; Wolff RA; Pant S; Lito K; Rangel K; Fellman B; Yuan Y; Lu KH; Sakellariou-Thompson D; Haymaker CL; Forget MA; Hwu P; Bernatchez C; Jazaeri AA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309721
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy against lung cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
Toyofuku T; Ishikawa T; Nojima S; Kumanogoh A
J Immunol; 2024 Mar; 212(5):917-927. PubMed ID: 38214607
[TBL] [Abstract] [Full Text] [Related]
20. Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma.
Yu T; Nie FQ; Zhang Q; Yu SK; Zhang ML; Wang Q; Wang EX; Lu KH; Sun M
Cell Death Dis; 2024 Jan; 15(1):12. PubMed ID: 38182561
[TBL] [Abstract] [Full Text] [Related]
[Next]
